Abnormality of the skeletal system
|
0.110 |
Biomarker
|
disease |
BEFREE |
Essential thrombocythemia in a child with elevated thrombopoietin concentrations and skeletal anomalies.
|
17455310 |
2008 |
Abnormality of the skeletal system
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Acquired amegakaryocytic thrombocytopenia
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
HCV infection might also induce autoantibodies to c-Mpl, resulting in the development of AAMT.
|
29085203 |
2017 |
Acquired amegakaryocytic thrombocytopenia
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
This rare AATP case presentation highlights the importance of a well-structured diagnostic approach to thrombocytopenia during pregnancy and supports the successful use of thrombopoietin agonists for the management of AATP.
|
31229978 |
2019 |
Acquired aplastic anemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
We measured the endogenous plasma concentration of TPO in 40 patients with acquired aplastic anaemia (AA) and in 32 patients with idiopathic thrombocytopenic purpura (ITP) by a sensitive Sandwich enzyme-linked immunosorbent assay (ELISA) and compared the results.
|
12150725 |
2002 |
Acquired thrombocytopenia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
To better understand the pathogenesis of thrombopoiesis in this hereditary thrombocytopenic disorder, we determined the percentage of reticulated platelets (RP), plasma glycocalicin (GC) and thrombopoietin (TPO) levels in 29 patients with CHMT, 23 patients with immune thrombocytopenic purpura (ITP), and 17 patients with thrombocytopenia secondary to decreased bone marrow megakaryocytes (hypoplasia).
|
10997880 |
2000 |
Acrocyanosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acute Chest Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Modest correlation was revealed between MPV and plasma thrombopoietin (TPO) measured at the first day of ACS (r = 0.279, P = 0.005).
|
23941967 |
2014 |
Acute leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We studied serum thrombopoietin (TPO) levels and circulating numbers of platelet during five courses of myelosuppressive post-remission chemotherapy in three patients with acute leukemia in complete remission.
|
9529122 |
1998 |
Acute lymphocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Primary leukemia cells separated from patients with B-precursor acute lymphoblastic leukemia with Ph1 or 11q23 translocation also showed the surface c-Mpl expression and a significant responsiveness to TPO.
|
10995006 |
2000 |
Acute Megakaryocytic Leukemias
|
0.020 |
Biomarker
|
disease |
BEFREE |
The supernatant of the transfected 293T cells stimulated the proliferation of a human megakaryoblastic leukemia cell line (UT-7/TPO) cells in a dose dependent manner, indicating that the feline TPO cDNA obtained in this study encodes biologically active feline TPO.
|
9880100 |
1998 |
Acute Megakaryocytic Leukemias
|
0.020 |
Biomarker
|
disease |
BEFREE |
Acute megakaryoblastic leukaemia with 3q inversion and elevated thrombopoietin (TSF): an autocrine role for TSF?
|
4084458 |
1985 |
Acute monocytic leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
However, it remains unclear, whether TPO mimetics influence the increase of blast cells and therefore to premature progression to AML.
|
28962071 |
2017 |
Acute pancreatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our data provide the first evidence for TPO as potential early prognostic biomarker in AP patients.
|
28079612 |
2017 |
Adult Acute Myeloblastic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we show that TPO, interleukin-3 (IL-3) and, at least in short-term assays, also interferon gamma (IFN gamma) induced proliferation in acute myeloid leukemia (AML-M7)-derived M-07e cells.
|
9766506 |
1998 |
Adult Myelodysplastic Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
|
16034467 |
2005 |
Alloimmune thrombocytopenia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Fetal alloimmune thrombocytopenia allows insight into the biology of TPO when fetal megakaryopoiesis is chronically stimulated.
|
11446655 |
2001 |
Amegakaryocytosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A plasma Tpo level <128 AU/ml excludes (negative predictive value 96%, 95% CI 90-99) severe asphyxia, congenital viral infections and amegakaryocytosis as the cause for thrombocytopenia in newborns.Increased plasma Tpo levels indicate that thrombocytopenia in newborns, as a result of various nonimmune disorders, is often caused by (temporary) bone marrow suppression/failure.
|
30759044 |
2020 |
Anemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The platelet change ratio (i.e., platelet count at week 4/platelet count at baseline) in the patients with developing anemia was correlated with the increase in the serum EPO level over 4 weeks (r = 0.88, P = 0.002), but not with the increase in the serum TPO level over 4 weeks.
|
22460221 |
2012 |
Anemia, Diamond-Blackfan
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Elevated thrombopoietin levels and alterations in the sequence of its receptor, c-Mpl, in patients with Diamond-Blackfan anemia.
|
15531462 |
2004 |
Anemia, Diamond-Blackfan
|
0.020 |
Biomarker
|
disease |
LHGDN |
We conclude that TPO enhances bone marrow erythropoiesis in patients with DBA in the presence of EPO and SCF and/or IL-3.
|
12041668 |
2002 |
Aplastic Anemia
|
0.090 |
Biomarker
|
disease |
BEFREE |
For acquired thrombocytopenias, data on TPO in aplastic anemia, immune thrombocytopenia, human immunodeficiency virus infection, and liver disease are given.
|
11446655 |
2001 |
Aplastic Anemia
|
0.090 |
GeneticVariation
|
disease |
LHGDN |
Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia.
|
12799278 |
2003 |
Aplastic Anemia
|
0.090 |
Biomarker
|
disease |
BEFREE |
Recombinant Human Thrombopoietin Promotes Platelet Engraftment and Improves Prognosis of Patients with Myelodysplastic Syndromes and Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.
|
28642072 |
2017 |
Aplastic Anemia
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
Eighteen of 19 patients with AA and a mean platelet count (MPC) of 18,000/microliters (2,000 to 61,000/microliters) had markedly elevated TPO levels (mean, 1,467 pg/mL; range, 597 to 3,834 pg/mL).
|
8639762 |
1996 |